Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ants Toi

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
European Urology|June 24, 2014
Obesity is associated with risk of progression for low-risk prostate cancers managed expectantlyBimal Bhindi, Girish S Kulkarni, Antonio Finelli, et al.
European Urology|February 27, 2014
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohortBimal Bhindi, Jennifer Locke, Shabbir M H Alibhai, et al.
Cancer Biology & Therapy|December 2, 2011
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohortRobert K Nam, William Zhang, Katherine Siminovitch, et al.
The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.
European Urology|May 14, 2013
A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progressionLih-Ming Wong, Shabbir M H Alibhai, Greg Trottier, et al.
Elife|May 1, 2016
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan additionJeremy L Praissman, Tobias Willer, M Osman Sheikh, et al.
European Urology Oncology|May 3, 2025
Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative GroupSunny B Nalavenkata, Emily Vertosick, Alberto Briganti, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Journal of the National Cancer Institute|April 5, 2017
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate CancerLaurent Briollais, Hilmi Ozcelik, Jingxiong Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2024
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian MenLiang Dong, Katherine Lajkosz, Rafael Sanchez-Salas, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
European Urology|June 24, 2014
Obesity is associated with risk of progression for low-risk prostate cancers managed expectantlyBimal Bhindi, Girish S Kulkarni, Antonio Finelli, et al.
European Urology|February 27, 2014
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohortBimal Bhindi, Jennifer Locke, Shabbir M H Alibhai, et al.
Cancer Biology & Therapy|December 2, 2011
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohortRobert K Nam, William Zhang, Katherine Siminovitch, et al.
The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.
European Urology|May 14, 2013
A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progressionLih-Ming Wong, Shabbir M H Alibhai, Greg Trottier, et al.
Elife|May 1, 2016
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan additionJeremy L Praissman, Tobias Willer, M Osman Sheikh, et al.
European Urology Oncology|May 3, 2025
Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative GroupSunny B Nalavenkata, Emily Vertosick, Alberto Briganti, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Journal of the National Cancer Institute|April 5, 2017
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate CancerLaurent Briollais, Hilmi Ozcelik, Jingxiong Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2024
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian MenLiang Dong, Katherine Lajkosz, Rafael Sanchez-Salas, et al.
Pageof 11